Captrust Financial Advisors Charles River Laboratories International, Inc. Transaction History
Captrust Financial Advisors
- $30.9 Billion
- Q2 2024
A detailed history of Captrust Financial Advisors transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 9,361 shares of CRL stock, worth $1.79 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,361
Previous 8,531
9.73%
Holding current value
$1.79 Million
Previous $2.31 Million
16.36%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding CRL
# of Institutions
730Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$971 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$399 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$364 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$261 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.7B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...